Matches in Wikidata for { <http://www.wikidata.org/entity/Q100425425> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q100425425 description "article scientifique publié en 2020" @default.
- Q100425425 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q100425425 description "scientific article published on 02 October 2020" @default.
- Q100425425 description "wetenschappelijk artikel" @default.
- Q100425425 description "наукова стаття, опублікована 2 жовтня 2020" @default.
- Q100425425 name "A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic reli" @default.
- Q100425425 name "A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic reli" @default.
- Q100425425 name "A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic reli" @default.
- Q100425425 type Item @default.
- Q100425425 label "A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic reli" @default.
- Q100425425 label "A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic reli" @default.
- Q100425425 label "A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic reli" @default.
- Q100425425 prefLabel "A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic reli" @default.
- Q100425425 prefLabel "A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic reli" @default.
- Q100425425 prefLabel "A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic reli" @default.
- Q100425425 P1433 Q100425425-1EC86E5C-A5CF-4505-9344-95CDC03FB01B @default.
- Q100425425 P1476 Q100425425-A8B922FA-C6BE-438C-A30F-670871C9FCDB @default.
- Q100425425 P2093 Q100425425-374F386C-226A-47AB-9029-DA8675D55986 @default.
- Q100425425 P2093 Q100425425-445C2D59-9FDC-4044-91A1-D249DA88EDA5 @default.
- Q100425425 P2093 Q100425425-54532F9C-6CC5-4F60-9B18-F943185D487F @default.
- Q100425425 P2093 Q100425425-7B4A096B-3CF7-4E23-88DB-FBB5249CD46D @default.
- Q100425425 P2093 Q100425425-804C2E0A-7DAC-45D2-81C7-A1009BB38AED @default.
- Q100425425 P2093 Q100425425-8BFC4D78-1B81-4459-AA8B-D6124C66999A @default.
- Q100425425 P2093 Q100425425-9A97E76F-E9DF-4B35-A86D-26A5FC591170 @default.
- Q100425425 P2093 Q100425425-A2707433-A9AB-475C-B99B-56F5E70DFDC0 @default.
- Q100425425 P2093 Q100425425-AB2C9060-5446-46E3-917D-FFF965F54EF8 @default.
- Q100425425 P2093 Q100425425-CA811189-D39B-4BB8-AA5C-74B4B08242A9 @default.
- Q100425425 P2093 Q100425425-D0150931-1E14-4D92-ABBB-73F841A70C42 @default.
- Q100425425 P2093 Q100425425-E7ABC4D3-21EC-4D74-B075-4F9645DEF628 @default.
- Q100425425 P2093 Q100425425-F2C1C3E4-42F8-432D-93DE-59CA2093386B @default.
- Q100425425 P2093 Q100425425-F5C30A98-EFFB-4BF8-B02A-3E18C7D371D1 @default.
- Q100425425 P304 Q100425425-91B14E29-34A6-4D9A-AD38-F5D7E9FA8E19 @default.
- Q100425425 P31 Q100425425-9D96026C-E311-418F-BE69-B05D690FD1AB @default.
- Q100425425 P356 Q100425425-04B88F0E-B007-40D7-AD2F-786C2893B1A5 @default.
- Q100425425 P433 Q100425425-1F26592C-06F8-4269-87A5-B952705F55FD @default.
- Q100425425 P478 Q100425425-FAF0B27C-C3C7-4296-88D3-55F979F37103 @default.
- Q100425425 P50 Q100425425-C2190F9D-9E35-4689-94A3-1772ACB732EE @default.
- Q100425425 P577 Q100425425-DE3A6001-538D-49FF-9EB8-168590A6769D @default.
- Q100425425 P698 Q100425425-A5EF5018-3ACE-46B6-8364-70834ADE4661 @default.
- Q100425425 P921 Q100425425-107E0A43-F446-4641-936E-5E96C8D0A1AD @default.
- Q100425425 P932 Q100425425-E1104AE5-0F7E-4602-BB82-8D11BEAA1134 @default.
- Q100425425 P356 S13063-020-04746-9 @default.
- Q100425425 P698 33008479 @default.
- Q100425425 P1433 Q7840023 @default.
- Q100425425 P1476 "A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial" @default.
- Q100425425 P2093 "Airi Takagi" @default.
- Q100425425 P2093 "Hajime Nakae" @default.
- Q100425425 P2093 "Koichiro Tanaka" @default.
- Q100425425 P2093 "Kotaro Nochioka" @default.
- Q100425425 P2093 "Masaru Mimura" @default.
- Q100425425 P2093 "Mosaburo Kainuma" @default.
- Q100425425 P2093 "Ryutaro Arita" @default.
- Q100425425 P2093 "Seiichi Kobayashi" @default.
- Q100425425 P2093 "Tadashi Ishii" @default.
- Q100425425 P2093 "Takao Namiki" @default.
- Q100425425 P2093 "Takashi Ito" @default.
- Q100425425 P2093 "Takuhiro Yamaguchi" @default.
- Q100425425 P2093 "Tetsuhiro Yoshino" @default.
- Q100425425 P2093 "Tomoaki Ishigami" @default.
- Q100425425 P304 "827" @default.
- Q100425425 P31 Q13442814 @default.
- Q100425425 P356 "10.1186/S13063-020-04746-9" @default.
- Q100425425 P433 "1" @default.
- Q100425425 P478 "21" @default.
- Q100425425 P50 Q46520445 @default.
- Q100425425 P577 "2020-10-02T00:00:00Z" @default.
- Q100425425 P698 "33008479" @default.
- Q100425425 P921 Q84263196 @default.
- Q100425425 P932 "7530547" @default.